A Four-Step Technique for Creating Individual Double-Eyelid Crease Shapes: A Free-Style Design

医学 眼睑 眼睑成形术 外科 患者满意度 限制 耐火材料(行星科学) 病历 机械工程 物理 天体生物学 工程类
作者
Linlang Suo,Jiaqi Li,Rao Fu,Yun Xie,Ru‐Lin Huang
出处
期刊:Plastic and Reconstructive Surgery [Ovid Technologies (Wolters Kluwer)]
卷期号:146 (4): 756-765 被引量:11
标识
DOI:10.1097/prs.0000000000007185
摘要

Background: Double-eyelid blepharoplasty is the most frequently performed aesthetic surgery in the Asian population. However, the epicanthal fold has been a conundrum limiting the outcomes of Asian blepharoplasty. Furthermore, with the blending of Western and Asian cultures, patients have individual standards of beauty for the upper eyelids. Here, we developed a four-step technique to form infold or outfold double-eyelid creases to satisfy individual patient requirements. Methods: The medical records of patients who simultaneously underwent double-eyelid blepharoplasty and epicanthoplasty using this four-step technique from January of 2017 to January of 2019 were reviewed. The results were grouped by preoperative patient requirements for eyelid crease shapes. The rate of meeting patient expectations in each group was evaluated by two independent observers. Preoperative and postoperative photographs were collected, complications were identified, and postoperative results were assessed. Results: In total, 285 consecutive patients were included in this study, with a mean follow-up period of 9 months. Of the 285 patients, 207 requested infold eyelid creases, and 190 (92 percent) procedures met patient expectations; and 78 patients requested outfold eyelid creases, and 69 (87 percent) procedures met patient expectations. A high rate of satisfaction with the final eyelid crease shape and resulting scarring was noted in both patient groups. The revision rate was 3 percent. No severe complications were observed. Conclusion: The four-step technique is a simple, flexible, and effective method for creating infold or outfold double-eyelid creases according to individual patient requirements and should be considered a routine method for patients who request double eyelids. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
mint-WANG完成签到,获得积分10
1秒前
122发布了新的文献求助10
1秒前
ice发布了新的文献求助10
2秒前
Godspeed发布了新的文献求助10
3秒前
4秒前
happyxuexi完成签到,获得积分10
4秒前
黄晓莉完成签到,获得积分10
5秒前
happyxuexi发布了新的文献求助10
7秒前
YYANG发布了新的文献求助10
9秒前
Orange应助黄晓莉采纳,获得10
10秒前
换胃思考完成签到 ,获得积分10
11秒前
ling应助阿斌采纳,获得10
11秒前
cookie完成签到,获得积分10
11秒前
12秒前
竹筏过海应助静静子采纳,获得100
13秒前
完美世界应助122采纳,获得10
14秒前
14秒前
英俊的铭应助大观天下采纳,获得10
16秒前
edsenone发布了新的文献求助10
17秒前
共享精神应助郑先生采纳,获得10
18秒前
馒头发布了新的文献求助10
20秒前
rice0601完成签到,获得积分10
21秒前
23秒前
公孙玲珑完成签到,获得积分10
25秒前
27秒前
花无缺完成签到,获得积分10
28秒前
29秒前
希望天下0贩的0应助WXT采纳,获得10
29秒前
29秒前
领导范儿应助YYANG采纳,获得10
29秒前
金坚发布了新的文献求助10
30秒前
在水一方应助完美的一天采纳,获得10
30秒前
郑先生发布了新的文献求助10
31秒前
大模型应助科研通管家采纳,获得10
32秒前
NexusExplorer应助科研通管家采纳,获得10
32秒前
酷波er应助科研通管家采纳,获得10
32秒前
桐桐应助科研通管家采纳,获得10
32秒前
32秒前
乐乐应助科研通管家采纳,获得10
32秒前
32秒前
高分求助中
请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
Yuwu Song, Biographical Dictionary of the People's Republic of China 700
[Lambert-Eaton syndrome without calcium channel autoantibodies] 520
Pressing the Fight: Print, Propaganda, and the Cold War 500
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
The Three Stars Each: The Astrolabes and Related Texts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2470871
求助须知:如何正确求助?哪些是违规求助? 2137600
关于积分的说明 5446785
捐赠科研通 1861599
什么是DOI,文献DOI怎么找? 925834
版权声明 562721
科研通“疑难数据库(出版商)”最低求助积分说明 495246